Date Fruit Effects in Type 2 Diabetes
Primary Purpose
Type2 Diabetes
Status
Completed
Phase
Not Applicable
Locations
Bahrain
Study Type
Interventional
Intervention
Dates
Raisins
Sponsored by

About this trial
This is an interventional other trial for Type2 Diabetes focused on measuring Type2 diabetes, Dates, Phytoestrogen
Eligibility Criteria
Inclusion Criteria:
- The diagnosis of type 2 diabetes will be based on the WHO guidelines. An HbA1C of 6.5% or greater, or 2 fasting plasma glucose readings of >7.0mmoll-1 or 2 random plasma glucose readings >11mmoll-1 in the absence of symptoms or concurrent illness or medication which might lead to hyperglycaemia (e.g. thiazide diuretics). Or one reading meets the diagnostic level with the presence of symptoms of polyuria, polydipsia, nocturia, fatigue or blurring of vision. The final diagnostic method of diagnosis type 2 diabetes is a positive oral glucose tolerance test (OGTT) using a 75g glucose load. If doubt exists on the diagnosis of diabetes an OGTT will be performed.
- Patients will be on stable medication for their diabetes, hypertension, lipids and gout (if appropriate) for 3 months prior to entry into the study.
- HbA1c 7.5 - 10%
- Patients between the ages of 45-75 years at the start of the study.
- Capable to give informed consent and complete the study.
Exclusion Criteria:
- Patients with concurrent illness or any medication in the last 3 months.
- Patients who are taking hormone replacement therapy.
- Patients who are currently or have taken antibiotics in the last 3 months.
- Currently enrolled in other clinical trials.
- Hba1c at recruiting stage of more than 10%.
- Patients with a BMI less than 20 and more than 40.
- Patients with known food allergies.
- Patients on insulin.
- Patients who are eating dates or raisins should be washed out for 4 weeks.
- Pregnant or nursing, or plans to become pregnant in the next 3 months, or not using adequate contraceptive measures.
Sites / Locations
- Royal College of Surgeons in Ireland - Bahrain
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Dates Arm
Raisins Arm
Arm Description
Consumption of Khalas dates (3 dates =30g undried dates) twice daily (phytoestrogen content 329ug/100g)
Consumption of Raisins (30g twice daily, phytoestrogen content of 9.6ug/100g)
Outcomes
Primary Outcome Measures
The effect of phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes
Measuring the levels of phytoestrogen and evaluate if it has reduced the average blood sugar levels over a period of 3 months.
Secondary Outcome Measures
Determine whether date phytoestrogens affect cardiovascular risk
Determine whether the level of phytoestrogens has lowered risks of cardiovascular disease by measuring the fasting lipids, C reactive protein and blood pressure.
Determine whether date phytoestrogens affect insulin resistance
Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations.
Full Information
NCT ID
NCT04616066
First Posted
October 25, 2020
Last Updated
October 3, 2022
Sponsor
Royal College of Surgeons in Ireland - Medical University of Bahrain
Collaborators
King Hamad University Hospital, Bahrain
1. Study Identification
Unique Protocol Identification Number
NCT04616066
Brief Title
Date Fruit Effects in Type 2 Diabetes
Official Title
Effect of Date Fruit Phytoestrogen on the Glycemic Control of Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
October 10, 2021 (Actual)
Primary Completion Date
April 30, 2022 (Actual)
Study Completion Date
May 30, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Royal College of Surgeons in Ireland - Medical University of Bahrain
Collaborators
King Hamad University Hospital, Bahrain
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Dried dates (Phoenix dactylifera) have the second highest phytoestrogen content of any fruit, only secondary to dried apricots with 329ug of phytoestrogens per 100g. The date palm is one of oldest planted trees on the earth at around 2,000 years old. Dates are nutritionally rich and a good source of fiber and carbohydrates and their potential medicinal and nutritional effects have been suggested in a number of studies. Date sugars have also been shown to be phenol rich, potent antioxidant, and strong inhibitor of α -glycosidase that may also have benefit in diabetes. In addition, dates are rich in micronutrients that may also have benefit for diabetes and insulin resistance . Dates have a glycemic index of 50 and studies have shown that the consumption of differing varieties of dates do not significantly affect the acute glycemia in patients with type 2 diabetes.
The objective of this study is to investigate the effect of date phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes in comparison to the same glycemic load of raisins that have low phytoestrogen content.
Detailed Description
Production and consumption of soy foods within Western countries have increased dramatically in the last decade with the postulated health benefits including improvement in bone health, relief of menopausal symptoms and reduced risk of certain types of cancers due to the soy phytoestrogens. In addition, habitual intake of soy phytoestrogens has also been associated with a reduced risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), which is of particular relevance given the increasing global prevalence of diabetes. This is a particular problem here in the Middle East and North Africa (MENA) region, where diabetes is considered as a serious and increasing health problem. According to the International Diabetes Federation the prevalence of diabetes in the MENA region is over 23.3%; however worldwide there is an epidemic increase in type 2 diabetes with the WHO report that approximately 415 million people have diabetes worldwide, and that by 2030, diabetes will be the 7th leading cause of death.
Dried dates (Phoenix dactylifera) have the second highest phytoestrogen content of any fruit, only secondary to dried apricots with 329ug of phytoestrogens per 100g. The date palm is one of oldest planted trees on the earth at around 2,000 years old. Dates are nutritionally rich and a good source of fiber and carbohydrates and their potential medicinal and nutritional effects have been suggested in a number of studies. Date sugars have also been shown to be phenol rich, potent antioxidant, and strong inhibitor of α -glycosidase that may also have benefit in diabetes. In addition, dates are rich in micronutrients that may also have benefit for diabetes and insulin resistance. Dates have a glycemic index of 50 and studies have shown that the consumption of differing varieties of dates do not significantly affect the acute glycemia in patients with type 2 diabetes.
There has not been a medium term study of the effect of date fruit in diabetes; therefore, this study will determine if the consumption Khalas dates (3 dates =30g undried dates) twice daily (phytoestrogen content 329ug/100g), in accord with that advised in the Holy Qur'an, will improve the glycemic control in men with type 2 diabetes, in comparison with the equivalent glycemic load of raisins (30g twice daily, phytoestrogen content of 9.6ug/100g). Each intervention will be taken as a snack mid-morning and mid-afternoon.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type2 Diabetes
Keywords
Type2 diabetes, Dates, Phytoestrogen
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a parallel, prospective, interventional and randomized trial involving 80 patients with type 2 diabetes. They will be randomised to either 60g of dates or 60g of raisins (amount split and given as a mid-morning and mid-afternoon snack) for 3 months.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
79 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Dates Arm
Arm Type
Experimental
Arm Description
Consumption of Khalas dates (3 dates =30g undried dates) twice daily (phytoestrogen content 329ug/100g)
Arm Title
Raisins Arm
Arm Type
Experimental
Arm Description
Consumption of Raisins (30g twice daily, phytoestrogen content of 9.6ug/100g)
Intervention Type
Other
Intervention Name(s)
Dates
Intervention Description
The effect of date phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes
Intervention Type
Other
Intervention Name(s)
Raisins
Intervention Description
The effect of raisins phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes
Primary Outcome Measure Information:
Title
The effect of phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes
Description
Measuring the levels of phytoestrogen and evaluate if it has reduced the average blood sugar levels over a period of 3 months.
Time Frame
90 days
Secondary Outcome Measure Information:
Title
Determine whether date phytoestrogens affect cardiovascular risk
Description
Determine whether the level of phytoestrogens has lowered risks of cardiovascular disease by measuring the fasting lipids, C reactive protein and blood pressure.
Time Frame
90 days
Title
Determine whether date phytoestrogens affect insulin resistance
Description
Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations.
Time Frame
90 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The diagnosis of type 2 diabetes will be based on the WHO guidelines. An HbA1C of 6.5% or greater, or 2 fasting plasma glucose readings of >7.0mmoll-1 or 2 random plasma glucose readings >11mmoll-1 in the absence of symptoms or concurrent illness or medication which might lead to hyperglycaemia (e.g. thiazide diuretics). Or one reading meets the diagnostic level with the presence of symptoms of polyuria, polydipsia, nocturia, fatigue or blurring of vision. The final diagnostic method of diagnosis type 2 diabetes is a positive oral glucose tolerance test (OGTT) using a 75g glucose load. If doubt exists on the diagnosis of diabetes an OGTT will be performed.
Patients will be on stable medication for their diabetes, hypertension, lipids and gout (if appropriate) for 3 months prior to entry into the study.
HbA1c 7.5 - 10%
Patients between the ages of 45-75 years at the start of the study.
Capable to give informed consent and complete the study.
Exclusion Criteria:
Patients with concurrent illness or any medication in the last 3 months.
Patients who are taking hormone replacement therapy.
Patients who are currently or have taken antibiotics in the last 3 months.
Currently enrolled in other clinical trials.
Hba1c at recruiting stage of more than 10%.
Patients with a BMI less than 20 and more than 40.
Patients with known food allergies.
Patients on insulin.
Patients who are eating dates or raisins should be washed out for 4 weeks.
Pregnant or nursing, or plans to become pregnant in the next 3 months, or not using adequate contraceptive measures.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Naji Alamuddin, Dr.
Organizational Affiliation
Royal College of Surgeons in Ireland - Bahrain
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royal College of Surgeons in Ireland - Bahrain
City
Manama
Country
Bahrain
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Monitoring, audits, and REC review will be permitted and provide direct access to source data and documents. The Lead PI and the researchers assigned by him will have access to the stored data/specimens. Only the Lead PI and the researchers assigned working on this study will be eligible to obtain the data/specimens from the participants during data collection.
IPD Sharing Time Frame
Dr Naji will act as the data custodian and is responsible for the storage, handling and quality of the study data.
Data will be collected in the case report form to allow for cross referencing to check validity.
Study documents (paper and electronic) will be retained in a secure (kept locked when not in use) location during and after the trial has finished. All essential documents including source documents will be retained for a period of 3 years after study completion (last patient, last study point). A label stating the date after which the documents can be destroyed will be placed on the inside front cover of the case notes of trial participants.
IPD Sharing Access Criteria
Study documents (paper and electronic) will be retained in a secure (kept locked when not in use) location during and after the trial has finished.
Citations:
PubMed Identifier
18492864
Citation
Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr. 2008 Jun;138(6):1244S-9S. doi: 10.1093/jn/138.6.1244S.
Results Reference
background
PubMed Identifier
12351466
Citation
Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002 Oct;25(10):1709-14. doi: 10.2337/diacare.25.10.1709.
Results Reference
background
PubMed Identifier
21984481
Citation
Xu SZ, Zeng B, Daskoulidou N, Chen GL, Atkin SL, Lukhele B. Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure. Toxicol Sci. 2012 Jan;125(1):56-68. doi: 10.1093/toxsci/kfr268. Epub 2011 Oct 9.
Results Reference
background
PubMed Identifier
16898863
Citation
Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer. 2006;54(2):184-201. doi: 10.1207/s15327914nc5402_5.
Results Reference
background
PubMed Identifier
22214443
Citation
Vayalil PK. Date fruits (Phoenix dactylifera Linn): an emerging medicinal food. Crit Rev Food Sci Nutr. 2012;52(3):249-71. doi: 10.1080/10408398.2010.499824.
Results Reference
background
PubMed Identifier
26225946
Citation
Hamad I, AbdElgawad H, Al Jaouni S, Zinta G, Asard H, Hassan S, Hegab M, Hagagy N, Selim S. Metabolic Analysis of Various Date Palm Fruit (Phoenix dactylifera L.) Cultivars from Saudi Arabia to Assess Their Nutritional Quality. Molecules. 2015 Jul 27;20(8):13620-41. doi: 10.3390/molecules200813620.
Results Reference
background
PubMed Identifier
21619670
Citation
Alkaabi JM, Al-Dabbagh B, Ahmad S, Saadi HF, Gariballa S, Ghazali MA. Glycemic indices of five varieties of dates in healthy and diabetic subjects. Nutr J. 2011 May 28;10:59. doi: 10.1186/1475-2891-10-59.
Results Reference
background
PubMed Identifier
24231017
Citation
Alkaabi J, Al-Dabbagh B, Saadi H, Gariballa S, Yasin J. Effect of traditional Arabic coffee consumption on the glycemic index of Khalas dates tested in healthy and diabetic subjects. Asia Pac J Clin Nutr. 2013;22(4):565-73. doi: 10.6133/apjcn.2013.22.4.09.
Results Reference
background
PubMed Identifier
12627179
Citation
Miller CJ, Dunn EV, Hashim IB. The glycaemic index of dates and date/yoghurt mixed meals. Are dates 'the candy that grows on trees'? Eur J Clin Nutr. 2003 Mar;57(3):427-30. doi: 10.1038/sj.ejcn.1601565.
Results Reference
background
PubMed Identifier
2727470
Citation
Senn SJ. Covariate imbalance and random allocation in clinical trials. Stat Med. 1989 Apr;8(4):467-75. doi: 10.1002/sim.4780080410.
Results Reference
background
PubMed Identifier
7997705
Citation
Senn S. Testing for baseline balance in clinical trials. Stat Med. 1994 Sep 15;13(17):1715-26. doi: 10.1002/sim.4780131703.
Results Reference
background
PubMed Identifier
22512015
Citation
Knol MJ, Groenwold RH, Grobbee DE. P-values in baseline tables of randomised controlled trials are inappropriate but still common in high impact journals. Eur J Prev Cardiol. 2012 Apr;19(2):231-2. doi: 10.1177/1741826711421688. No abstract available.
Results Reference
background
Learn more about this trial
Date Fruit Effects in Type 2 Diabetes
We'll reach out to this number within 24 hrs